Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway

Metformin, as the first-line oral drug for type 2 diabetes, has proven benefits against aging, cancer and cardiovascular diseases. But the influence of metformin to the immune response and its molecular mechanisms remain obscure. Metformin increases resistance to not only the Gram-negative pathogens...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Virulence
Glavni autori: Xiao, Yi, Liu, Fang, Li, Sanhua, Jiang, Nian, Yu, Changyan, Zhu, Xinting, Qin, Ying, Hui, Jing, Meng, Lingjie, Song, Changwei, Li, Xiao-Fei, Liu, Yun
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2019
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961722/
https://ncbi.nlm.nih.gov/pubmed/31851866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21505594.2019.1706305
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items